Cancer Incidence and Mortality among Non-Hispanic Whites, New York City, 2012-2016

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 17939.4 497.9 494.6-501.3 8649.6 524.1 519.1-529.2 9289.8 488.4 483.7-493.1 5774.4 146.7 145.0-148.5 2822.2 167.9 165.1-170.7 2952.2 132.5 130.3-134.8
Oral cavity and pharynx 377.6 10.5 10.1-11.0 253.8 15.4 14.5-16.3 123.8 6.4 5.8-6.9 79.6 2.1 1.9-2.3 54.2 3.2 2.8-3.6 25.4 1.2 1.0-1.4
Esophagus 140.4 3.8 3.5-4.1 100.8 6.1 5.6-6.6 39.6 1.8 1.5-2.0 115.0 3.0 2.8-3.3 81.8 4.9 4.5-5.4 33.2 1.4 1.2-1.6
Stomach 306.0 8.1 7.7-8.6 182.0 11.0 10.3-11.8 124.0 5.8 5.3-6.3 149.4 3.7 3.5-4.0 88.6 5.3 4.8-5.8 60.8 2.6 2.3-2.9
Colorectal 1478.4 39.9 39.0-40.9 752.2 45.9 44.4-47.4 726.2 35.1 33.9-36.4 547.2 13.6 13.1-14.2 265.2 15.8 15.0-16.7 282.0 11.9 11.3-12.6
Colon excluding rectum 1067.6 28.3 27.5-29.1 528.0 32.1 30.9-33.4 539.6 25.4 24.4-26.4 456.8 11.2 10.8-11.7 218.8 13.0 12.2-13.8 238.0 9.9 9.4-10.6
Rectum & rectosigmoid 410.8 11.6 11.1-12.1 224.2 13.8 13.0-14.6 186.6 9.8 9.1-10.4 90.4 2.4 2.2-2.6 46.4 2.8 2.5-3.2 44.0 2.0 1.7-2.3
Liver / intrahepatic bile duct 285.6 7.6 7.2-8.0 196.6 11.5 10.7-12.2 89.0 4.3 3.8-4.7 201.0 5.2 4.8-5.5 132.4 7.8 7.2-8.4 68.6 3.0 2.7-3.4
Pancreas 563.8 14.5 14.0-15.1 281.2 16.8 15.9-17.7 282.6 12.6 12.0-13.4 461.4 11.6 11.1-12.1 229.4 13.6 12.8-14.4 232.0 9.9 9.3-10.6
Larynx 116.4 3.1 2.9-3.4 96.0 5.7 5.2-6.3 20.4 1.0 0.8-1.2 33.8 0.9 0.7-1.0 27.4 1.6 1.3-1.9 6.4 0.3 0.2-0.5
Lung and bronchus 2120.8 55.7 54.6-56.8 1024.8 61.1 59.4-62.8 1096.0 52.0 50.6-53.5 1310.2 33.5 32.7-34.3 674.6 40.0 38.7-41.4 635.6 28.8 27.7-29.8
Melanoma of the skin 796.8 22.4 21.7-23.2 443.2 27.3 26.1-28.5 353.6 18.9 18.0-19.9 88.6 2.3 2.1-2.6 54.0 3.2 2.9-3.7 34.6 1.6 1.4-1.9
Female breast             2585.0 144.7 142.1-147.4             455.0 21.3 20.3-22.2
Cervix uteri             113.0 7.0 6.4-7.6             38.4 2.1 1.8-2.4
Corpus uterus and NOS             652.4 34.0 32.8-35.3             126.2 5.9 5.5-6.4
Ovary             262.6 14.2 13.4-15.1             174.4 8.4 7.8-9.0
Prostate       1803.0 104.8 102.7-107.1             266.0 15.5 14.6-16.3      
Testis       121.0 8.2 7.5-8.9             3.4 0.2 0.1-0.4      
Urinary bladder (incl. in situ) 959.0 24.8 24.1-25.5 725.2 43.4 42.0-44.9 233.8 10.6 10.0-11.3 199.2 4.6 4.3-4.9 138.0 8.0 7.4-8.7 61.2 2.3 2.1-2.6
Kidney and renal pelvis 579.2 16.4 15.7-17.0 382.4 23.3 22.3-24.4 196.8 10.3 9.6-11.0 119.2 3.0 2.8-3.3 74.8 4.5 4.0-5.0 44.4 1.9 1.6-2.2
Brain and other central nervous system 259.4 8.1 7.6-8.6 138.2 9.2 8.5-9.9 121.2 7.1 6.5-7.7 151.8 4.3 3.9-4.6 77.8 4.9 4.4-5.4 74.0 3.7 3.3-4.2
Thyroid 839.6 27.4 26.5-28.3 237.0 15.5 14.6-16.5 602.6 39.4 37.9-40.9 24.2 0.6 0.5-0.7 10.2 0.6 0.4-0.8 14.0 0.6 0.5-0.8
Hodgkin lymphoma 118.8 4.2 3.8-4.5 61.2 4.4 3.9-4.9 57.6 4.0 3.5-4.5 14.4 0.4 0.3-0.5 7.4 0.5 0.3-0.6 7.0 0.4 0.2-0.5
Non-Hodgkin lymphomas 883.0 24.7 23.9-25.5 480.0 30.0 28.8-31.2 403.0 20.3 19.3-21.2 224.0 5.5 5.2-5.9 119.6 7.2 6.6-7.8 104.4 4.2 3.9-4.7
Myeloma 270.6 7.2 6.8-7.6 159.2 9.5 8.9-10.2 111.4 5.3 4.8-5.8 100.2 2.5 2.3-2.8 56.2 3.3 3.0-3.8 44.0 1.9 1.7-2.2
Leukemias 651.2 18.1 17.5-18.8 374.4 23.4 22.3-24.5 276.8 13.9 13.2-14.8 266.6 6.9 6.5-7.3 150.0 9.1 8.5-9.8 116.6 5.3 4.8-5.8

Notes

  • Incidence data are provisional, November 2018.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.